» Articles » PMID: 9624140

Purified Recombinant Fmrp Exhibits Selective RNA Binding As an Intrinsic Property of the Fragile X Mental Retardation Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Jun 23
PMID 9624140
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Fragile X syndrome is caused by the transcriptional silencing of the FMR1 gene due to a trinucleotide repeat expansion. The encoded protein, Fmrp, has been found to be a nucleocytoplasmic RNA-binding protein containing both KH domains and RGG boxes that associates with polyribosomes as a ribonucleoprotein particle. RNA binding has previously been demonstrated with in vitro-translated Fmrp; however, it remained uncertain whether the selective RNA binding observed was an intrinsic property of Fmrp or required an associated protein(s). Here, baculovirus-expressed and affinity-purified FLAG-tagged murine Fmrp was shown to bind directly to both ribonucleotide homopolymers and human brain mRNA. FLAG-Fmrp exhibited selectivity for binding poly(G) > poly(U) >> poly(C) or poly(A). Moreover, purified FLAG-Fmrp bound to only a subset of brain mRNA, including the 3' untranslated regions of myelin basic protein message and its own message. Recombinant isoform 4, lacking the RGG boxes but maintaining both KH domains, was also purified and was found to only weakly interact with RNA. FLAG-purified I304N Fmrp, harboring the mutation of severe fragile X syndrome, demonstrated RNA binding, in contrast to previous suggestions. These data demonstrate the intrinsic property of Fmrp to selectively bind RNA and show FLAG-Fmrp as a suitable reagent for structural characterization and identification of cognate RNA ligands.

Citing Articles

Characterization of Fragile X Mental Retardation Protein expression in human nociceptors and their axonal projections to the spinal dorsal horn.

Mitchell M, Cook L, Shiers S, Tavares-Ferreira D, Akopian A, Dussor G J Comp Neurol. 2023; 531(7):814-835.

PMID: 36808110 PMC: 10038933. DOI: 10.1002/cne.25463.


The molecular biology of FMRP: new insights into fragile X syndrome.

Richter J, Zhao X Nat Rev Neurosci. 2021; 22(4):209-222.

PMID: 33608673 PMC: 8094212. DOI: 10.1038/s41583-021-00432-0.


Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Majumder M, Johnson R, Palanisamy V Crit Rev Biochem Mol Biol. 2020; 55(5):409-424.

PMID: 32878499 PMC: 7695039. DOI: 10.1080/10409238.2020.1810621.


Cataloguing and Selection of mRNAs Localized to Dendrites in Neurons and Regulated by RNA-Binding Proteins in RNA Granules.

Ohashi R, Shiina N Biomolecules. 2020; 10(2).

PMID: 31978946 PMC: 7072219. DOI: 10.3390/biom10020167.


Long Noncoding RNA Can Be a Probable Mechanism and a Novel Target for Diagnosis and Therapy in Fragile X Syndrome.

Huang G, Zhu H, Wu S, Cui M, Xu T Front Genet. 2019; 10:446.

PMID: 31191598 PMC: 6541098. DOI: 10.3389/fgene.2019.00446.